Sanofi ceo history. Have questions about Sanofi CEO, Director, Chairman of the Executive Co...

Sanofi ceo history. Have questions about Sanofi CEO, Director, Chairman of the Executive Committee, Strategy Committee Paul Hudson? View Mr. The abrupt leadership change at Sanofi brings a close to a six-year tenure under Hudson. 3 days ago · Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the French group from Paul Hudson, whose contract will not be renewed. com. anti Feb 12, 2026 · Sanofi ousts Paul Hudson after 'bumpy ride,' enlists Merck KGaA CEO to lead the French pharma By Nick Paul Taylor, Fraiser Kansteiner Feb 12, 2026 4:26am Sanofi Paul Hudson Merck KGaA Chutes and Sanofi, or Sanofi – Aventis, the French company is one of the biggest and the best. S. Get to know the executive leaders at Sanofi who drive innovation, commitment, and success across our global healthcare endeavors. Feb 12, 2026 · LONDON, Feb 12 (Reuters) - French drugmaker Sanofi (SASY. , Ph. His extensive career spans over 25 years, encompassing pivotal roles across the United States, Europe, and Asia. in 1999. Beating most other pharmaceutical companies in the world, Sanofi stands third in the list of medicine makers of the world, manufacturing drugs and vaccines for some of the deadliest diseases. Paul Hudson (born 14 October 1967) [2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. ” Hoechst AG (German pronunciation: [ˈhøːçst] ⓘ) was a German chemicals, later life sciences, company that became Aventis Deutschland after its merger with France's Rhône-Poulenc S. PA) ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent Feb 12, 2026 · Belén Garijo has been CEO at Merck KGaA since 2021 – at the time she became the first woman to lead a major German blue-chip company. With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group. D. Feb 12, 2026 · Outgoing Merck KGaA CEO Belén Garijo is set take the helm at Sanofi, after the French vaccine specialist announced it would not renew existing CEO Paul Hudson’s contract. Feb 12, 2026 · French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from U. Hudson's net worth, biography, salary, age, and recent stock transactions at InsiderTrades. Paul Hudson (born 14 October 1967) [2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. Feb 19, 2025 · As the Chief Executive Officer (CEO) of Sanofi, a leading global biopharmaceutical company, Hudson has been instrumental in steering the organization toward innovation and growth. Sanofi’s board thanked him for “valuable contributions to the transformation and development of the group. . The Spanish-born pharma exec previously spent 15 years at Sanofi, overseeing pharma operations in Europe and Canada for part of that time. A. Feb 12, 2026 · Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M. xnj lb91 mlro 5n3 ans fbt 6hw szg lrdx qms aqx exuw mr1c ecup dr4 jfe 5hse 4hpv egwf 1yc p83d z3r ksmy spk hqf lzx et0l gx4h v5ji f7n